These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6670692)

  • 1. [Platelet antiaggregants and bleeding time lengthening: management in the preoperative period].
    Thébault JJ; Blatrix C; Blanchard J; Panak E
    Agressologie; 1983 Dec; 24(12):609-11. PubMed ID: 6670692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in platelet aggregation during treatment with acetylsalicylic acid. Sensitivity of various aggregating agents].
    Lecrubier C; Conard J; Horellou MH; Kher A; Samama M
    Therapie; 1982; 37(5):581-6. PubMed ID: 7179328
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 6. The interactions of ticlopidine and aspirin in normal subjects.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    J Int Med Res; 1977; 5(6):405-11. PubMed ID: 590598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
    Renner C; Guilmet D; Curtet JM
    Nouv Presse Med; 1980 Nov; 9(43):3249-51. PubMed ID: 7454568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between bleeding time and antithrombotic effect of platelet-suppressive agents in rat experimental model.
    Suehiro A; Oura Y; Ueda M; Kakishita E
    Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):157-63. PubMed ID: 8202629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of blood coagulability and effects of the platelet aggregation inhibitor (ticlopidine) in experimental subarachnoid hemorrhage in dogs].
    Toyoda O; Nukui H; Horikoshi S; Mitsuka S; Sasaki H; Tamada J; Miyagi O; Shibasaki T; Ohe C
    Neurol Med Chir (Tokyo); 1985 Oct; 25(10):810-7. PubMed ID: 2417133
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bleeding time and cardioactive drugs. Effects of dipyridamole and carbochromen].
    Rubegni M; De Mauro G; Provvedi D; Bandinelli C; Bellini PG
    Boll Soc Ital Cardiol; 1975; 20(8):875-80. PubMed ID: 1233046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmazie in unserer Zeit 4/2009].
    Alban S; Dingermann T
    Pharm Unserer Zeit; 2009; 38(4):295. PubMed ID: 19572344
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombus formation and its prevention during extracorporeal circulation--effect of preoperative administration with the antiplatelet drugs].
    Takayama T
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Dec; 32(12):2076-89. PubMed ID: 6530570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
    Breitkreutz J
    Pharm Unserer Zeit; 2009; 38(4):330-7. PubMed ID: 19572353
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kinetics of I-131 fibrinogen in cancer patients: pharmacological approach].
    Boneu-Valmalette A; Bugat R; David JF; Combes PF
    C R Seances Soc Biol Fil; 1977; 171(6):1293-6. PubMed ID: 148961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
    Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A
    Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C
    Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine and platelet function.
    Lecompte T; Lecrubier C; Potevin F; Samama M
    Thromb Haemost; 1986 Jun; 55(3):437-8. PubMed ID: 3529484
    [No Abstract]   [Full Text] [Related]  

  • 19. A possible method to control prolongations of bleeding time under antiplatelet therapy with ticlopidine.
    Thébault J; Blatrix C; Blanchard J; Panak E
    Thromb Haemost; 1982 Aug; 48(1):6-8. PubMed ID: 7135344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine as an experimental antithrombotic agent.
    Vallée E; Maffrand JP; Bernat A; Delebassée D; Tissinier A
    Agents Actions Suppl; 1984; 15():50-9. PubMed ID: 6592945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.